Brief: Acumen Pharmaceuticals Reports Results For Q2 2022

Acumen Pharmaceuticals

15/08/2022 22:17

Aug 15 (Reuters) - Acumen Pharmaceuticals Inc  ABOS.O :
    * ACUMEN PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR
SECOND
QUARTER 2022 AND BUSINESS HIGHLIGHTS
    * ACUMEN PHARMACEUTICALS INC - $209.9 MILLION IN CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES AS OF JUNE 30, 2022
    * ACUMEN PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.25
    * ACUMEN PHARMACEUTICALS INC - TOPLINE RESULTS EXPECTED IN
FIRST
HALF OF 2023 FROM INTERCEPT-AD, PHASE 1 CLINICAL TRIAL OF ACU193

Source text for Eikon:  ID:nGNX37d64g 
Further company coverage:  ABOS.O 

 ((Reuters.Briefs@thomsonreuters.com;))